On May 21, SeaTown Holdings International (SeaTown) announced an investment of $115 million via SeaTown Private Capital Master Fund (SeaTown PCap Fund) in AddVita, a Singapore-headquartered healthcare and life sciences distribution company.
Backed by SeaTown PCap Fund, AddVita specialises in distributing medical, laboratory and pharmaceutical products and services.
With the long-term vision and a decentralised approach, the firm also focuses on a ‘buy and build’ strategy to strategically acquire market-leading niche businesses specialising in the healthcare and life sciences distribution field with good finances.
Through these targeted investments and strategic partnerships, AddVita will establish a platform of high-quality products and services that improve access and quality of healthcare across Asia to work towards their vision of creating a healthier future and transform healthcare accessibility and quality through focus on innovation and collaboration.
With over a decade of private equity experience in Asia and more than US$400 million ($516.4 million) committed into buy-and-build investment opportunities, SeaTown is well positioned to partner with AddVita to continue supporting their execution of their ‘buy-and-build’ strategy which aims to promote scalable growth and value creation for AddVita.
“We are excited to support AddVita in its mission to empower small and medium-sized businesses, enhancing healthcare access and quality across Asia. The healthcare distribution sector is resilient, with robust secular growth tailwinds. Our high-quality partners have also demonstrated the ability to generate strong cash flow and sustainable earnings growth,” says Dickson Loo, managing director of private equity and SeaTown.
See also: Ex-Temasek India executives target US$400 million for fund debut
“With SeaTown’s partnership, we are confident that AddVita will emerge as a leader in the region’s healthcare distribution sector, unlocking significant value creation opportunities,” Loo adds.
